Breaking News

Glaxo to Pay $488.7 Million Fine to End China Corruption Probe
Tweet TWEET

Anheuser-Busch InBev 92PF Publication of Supplementary Prospectus

  Anheuser-Busch InBev (92PF) - Publication of Supplementary Prospectus

RNS Number : 3516Q
Anheuser-Busch InBev SA/NV
05 November 2012




                             RNS PUBLICATION FORM



Publication of Supplementary Prospectus



The following supplementary  prospectus has  been approved by  the UK  Listing 
Authority and is available for viewing:



Supplementary  prospectus   dated   5  November   2012   (the   "Supplementary 
Prospectus"), supplementary  to  the base  prospectus  dated 16  May  2012  as 
previously supplemented by  a supplementary prospectus  dated 16 August  2012, 
relating to the €15,000,000,000 Euro  Medium Term Note Programme of  Brandbrew 
S.A. and Anheuser-Busch InBev SA/NV (the "Prospectus").



To view the Supplementary Prospectus please  paste the following URL into  the 
address bar of your browser:



http://www.rns-pdf.londonstockexchange.com/rns/3516Q_-2012-11-5.pdf




To view the  Form 6-K incorporating  Anheuser-Busch InBev's Unaudited  Interim 
Report for the 9 month period ended 30 September 2012 as filed with the United
States Securities Exchange Commission on 31 October 2012 (the "2012 Nine Month
Results"),  which  is  incorporated   by  reference  into  the   Supplementary 
Prospectus, please  paste the  following  URL into  the  address bar  of  your 
browser:



http://www.rns-pdf.londonstockexchange.com/rns/3516Q_1-2012-11-5.pdf



The Supplementary Prospectus and  the 2012 Nine Month  Results have each  been 
submitted to the National Storage Mechanism and will shortly be available  for 
inspection at: www.Hemscott.com/nsm.do



For further information, please contact



Benoit Loore or Ann Randon



Email: Benoit.Loore@ab-inbev.com, Ann.Randon@ab-inbev.com



Anheuser-Busch InBev SA/NV

Brouwerijplein 1

3000 Leuven

Belgium



DISCLAIMER - INTENDED ADDRESSEES



Please note that the information contained in the Supplementary Prospectus may
be addressed to  and/or targeted at  persons who are  residents of  particular 
countries (specified in the Prospectus) only  and is not intended for use  and 
should not be relied upon by any person outside these countries and/or to whom
the offer contained in the Supplementary Prospectus is not addressed. Prior to
relying on the information contained in the Supplementary Prospectus you  must 
ascertain from the  Prospectus whether  or not you  are part  of the  intended 
addressees of the  information contained  therein. Your right  to access  this 
service is conditional upon complying with the above requirement.



                     This information is provided by RNS
           The company news service from the London Stock Exchange

END


PDIEALFSEEXAFFF -0- Nov/05/2012 14:10 GMT
 
Press spacebar to pause and continue. Press esc to stop.